Treatment of Mild and Subthreshold Depressive Disorders

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the efficacy of a SSRI, cognitive-bahavioral-therapy and a free choice between SSRI and CBT in a sample of primary care patients suffering from mild to moderate depression.

Hypotheses:

• SSRI is superior to placebo

• CBT is superior to a non-specific supporting group therapy

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ludwig-Maximilians - University of Munich
• Treatments: Serotonin; Serotonin Uptake Inhibitors

Criteria

Inclusion Criteria:(e.g.)

• subthreshold and mild depressive disorders including dysthymia (HAMD: 8-22)

• informed consent

• 18 years

Exclusion Criteria:(e.g.)

• severe mood disorders

• bipolar disorder

• recurrent brief depression

• suicidality

• alcohol or drug dependency

• obsessive-compulsive disorder

• schizoaffective disorder / schizophrenia

• pregnancy